Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/16271785

Download in:

View as

General Info

PMID
16271785